Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Inflammatory and Regulatory Eosinophil Subpopulations: the Path to Precision Medicine for the Treatment of Eosinophilic-associated Diseases

NCT06911775 is registered in ClinicalTrials.gov with University of Florence as lead sponsor.

NCT NCT06911775
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06911775 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Inflammatory and Regulatory Eosinophil Subpopulations: the Path to Precision Medicine for the Treatment of Eosinophilic-associated Diseases
Lead sponsor
University of Florence
Phase
Observational
Overall status
Not yet recruiting
Start date
April 30, 2025
Completion date
December 31, 2026
Enrollment
160 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

eosinophilic asthma, eosinophilic granulomatosis with polyangiitis (egpa), hypereosinophilic syndrome (hes)